You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

Citation Tools

Article menu

Download PDFPDF

XML
Research Article
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mullins SR, Vasilakos JP, Deschler K, et al
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Journal for ImmunoTherapy of Cancer 2019;7:244. doi: 10.1186/s40425-019-0724-8